Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2009
10/22/2009WO2009106580A8 Method for identifying inhibitors against viruses that use a class i fusion protein
10/22/2009WO2009094666A3 Cryoaggregate filtration for the treatment of cardiomyopathy and other autoimmune diseases
10/22/2009WO2009094642A3 Assay preparation plates, fluid assay preparation and analysis systems, and methods for preparing and analyzing assays
10/22/2009WO2009094623A3 Method for discriminating between malignant and benign tissue lesions
10/22/2009WO2009094383A3 Quantitation of lobular involution for breast cancer risk prediction
10/22/2009WO2009094076A3 Pass-fail tool for testing particulate contamination level in a fluid
10/22/2009WO2009091581A3 Diagnostic biomarkers for vascular aneurysm
10/22/2009WO2009091556A3 Diagnostic methods and kits using fibroblast growth factor-23
10/22/2009WO2009091186A3 Health diagnosis system using bio-disc and method for diagnosing health using the same
10/22/2009WO2009089066A3 Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
10/22/2009WO2009088209A3 Method for selective labeling of protein produced by in vitro translation by using a marker from trna prepared by using in vitro transcription
10/22/2009WO2009085016A8 Nanostructures, methods of preparing and uses thereof
10/22/2009WO2009083252A3 Method for enriching phosphopeptides
10/22/2009WO2009070767A3 Systemic instigation systems to study tumor growth or metastasis
10/22/2009WO2009068862A8 Electrochemical detection of a metal - labelled analyte
10/22/2009WO2009058908A3 Methods for prognosing the ability of a zearalenone analog compound to treat cancer
10/22/2009WO2009058853A3 Hybrid microfluidic spr and molecular imaging device
10/22/2009WO2009048673A3 Stochastic confinement to detect, manipulate, and utilize molecules and organisms
10/22/2009WO2009018307A3 Analysis of polypeptide production
10/22/2009WO2006050352A9 Blood test prototypes and methods for the detetion of circulating tumor and endothelial cells
10/22/2009WO2001000878A9 A novel vascular endothelial growth factor family member and uses thereof
10/22/2009US20090265797 Novel Anti-IGF-IR Antibodies and Uses Thereof
10/22/2009US20090265116 Prediction of an individual's risk of developing rheumatoid arthritis
10/22/2009US20090265113 System and method for testing heat exchange system for heat exchange catheter
10/22/2009US20090264631 Immunoadsorption of anti-von willebrand factor cleaving protease antibodies
10/22/2009US20090264624 Human cytokine receptor
10/22/2009US20090264618 Compounds With a Branched Linker
10/22/2009US20090264528 Serine palmitoylcoa transferase (spt) inhibition by myriocin or genetic deficiency decreases cholesterol absorption
10/22/2009US20090264526 Natural ligand of G protein coupled receptor RCC356 and uses thereof
10/22/2009US20090264464 Antitumor agent for undifferentiated gastric cancer
10/22/2009US20090264381 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/22/2009US20090264370 Polypeptides homologous to vegf and bmp1
10/22/2009US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
10/22/2009US20090264362 Influenza virus inhibiting peptides
10/22/2009US20090264361 Identification of a family of secreted proteins in vascular endothelium
10/22/2009US20090264360 Cloning and expression of gonadotropin-releasing hormone (GnRH) receptors
10/22/2009US20090264338 Inhibitor of Insulin Multimer Formation
10/22/2009US20090264316 Ultraviolet/Ozone Patterned Organosilane Surfaces
10/22/2009US20090264314 Optical Detection of Label-Free Biomolecular Interactions Using Microreplicated Plastic Sensor Elements
10/22/2009US20090264310 Screening method for the isolation of centrosomal cluster-inhibitors as anti-cancer agents
10/22/2009US20090264305 Polynucleotide Marker Genes and their Expression, for Diagnosis of Endotoxemia
10/22/2009US20090264303 Polypeptides having a functional domain of interest and methods of identifying and using same
10/22/2009US20090264301 Methods utilizing differential splicing events in blood cells for the detection of pathological events
10/22/2009US20090263917 Method for the quality control of molecules or targets
10/22/2009US20090263916 Antagonists of HMG1 for treating inflammatory conditions
10/22/2009US20090263915 Agglutination inhibition assay method and reagent
10/22/2009US20090263914 Bioanalytical assay
10/22/2009US20090263911 End point detection method , end point detection device, and gas phase reaction processing apparatus equipped with end point detection device
10/22/2009US20090263910 Method for measuring hypochlorite ion
10/22/2009US20090263909 Treatment of nucleic acid
10/22/2009US20090263908 Liquid crystal condensation of nucleic acid (na) complexes
10/22/2009US20090263907 Reagent for lead concentration determination and method of determining lead concentration
10/22/2009US20090263906 Method of antioxidative functional estimation using animal model
10/22/2009US20090263905 Detection test assembly for detecting the presence of a substance in a sample
10/22/2009US20090263903 Method for determining prothrombin time
10/22/2009US20090263901 Stable neural stem cell lines
10/22/2009US20090263883 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
10/22/2009US20090263856 Apparatus and Method for Detecting Live Cells with an Integrated Filter and Growth Detection Device
10/22/2009US20090263852 Nonapoptotic forms of cell death and methods of modulation
10/22/2009US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
10/22/2009US20090263843 Protein labeling with cyanobenzothiazole conjugates
10/22/2009US20090263840 Novel Monoclonal Anitbody and Use thereof
10/22/2009US20090263839 Acetaminophen-protein adduct assay device and method
10/22/2009US20090263838 Method for determining a lung cancer treatment and method for determining the effectiveness of an agent for treatment of lung cancer
10/22/2009US20090263837 Method of minimizing reagent consumption in microplate-based reactions
10/22/2009US20090263836 Botulinum toxin screening assays
10/22/2009US20090263835 Genes that are Up- or Down-Regulated During Differentiation of Human Embryonic Stem Cells
10/22/2009US20090263834 Droplet Actuator Devices and Methods for Immunoassays and Washing
10/22/2009US20090263833 In vitro estimation of in vivo half-life binding proteins
10/22/2009US20090263832 Reagents for the Detection of Protein Phosphorylation in Leukemia Signaling Pathways
10/22/2009US20090263831 Ubiquitin ligase assay
10/22/2009US20090263830 Visualization and quantitiation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
10/22/2009US20090263829 Alzheimer's disease biomarkers and methods of use
10/22/2009US20090263828 Novel assay for precursor T-cells having high proliferative capacity (PHPC-asay)
10/22/2009US20090263827 Method for determining health status by analyzing analytes
10/22/2009US20090263826 Means and method for diagnosing hemolytic anemia
10/22/2009US20090263825 Methods, immunoassays and devices for detection of anti-lipoidal antibodies
10/22/2009US20090263824 Detection of Neurodegenerative Disease
10/22/2009US20090263823 Glyceroglycolipid antigen of mycoplasma pneumoniae
10/22/2009US20090263822 In Vitro Procedure for Diagnosis and Early Diagnosis of Neurodegenerative Diseases
10/22/2009US20090263821 Ubiquitin Ligase Assays And Related Reagents
10/22/2009US20090263812 Use of id4 for diagnosis and treatment of cancer
10/22/2009US20090263810 Bisulfite conversion of dna
10/22/2009US20090263808 Genetic Analysis For Stratification of Cancer Risk
10/22/2009US20090263801 Phenotype-Genotype Relationship in Age-Related Macular Degeneration
10/22/2009US20090263792 measurement of the expression of specific proteins and/or their genes in skin cells and/or skin tissues, wherein the specific proteins change their expression with inflammation caused by atopic dermatitis or change their expression according to the degree of predisposition to atopic dermatitis
10/22/2009US20090263790 Methods for Identifying Functionally Related Genes and Drug Targets
10/22/2009US20090263788 Efficient algorithm for pcr testing of blood samples
10/22/2009US20090263787 method for screening of infectious agents in blood
10/22/2009US20090263786 Mass spectrometric analysis method
10/22/2009US20090263785 Modified HIV-1 Peptides and Use Thereof in the Detection of Anit-HIV Antibodies
10/22/2009US20090263784 Three-dimensional structure of prostaglandin d synthase and utilization thereof
10/22/2009US20090263496 Method for producing metal particles, metal particles produced thereby, and the use thereof
10/22/2009US20090263492 Diagnostic Methods and Genetic Markers for Alzheimer Disease
10/22/2009US20090263485 Targeted hollow gold nanostructures and methods of use
10/22/2009US20090263474 Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
10/22/2009US20090263417 Multi-subtype FIV vaccines
10/22/2009US20090263404 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
10/22/2009US20090263403 DNAX Accessory Protein, 12 kD (DAP12); useful in modulating development of cells such as lymphoid and myeloid; for modulating of immune responses; fusion proteins
10/22/2009US20090263400 Osteoporosis associated markers and methods of use thereof
1 ... 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 ... 3937